BLT-3
BLT-3 is an inhibitor of scavenger receptor class B type I (SR-BI) that exerts reversible, non-cell-type-specific inhibitory effects on SR-BI-mediated lipid transport. BLT-3 inhibits SR-BI-mediated selective lipid uptake from HDL as well as cholesterol efflux from cells to HDL. BLT-3 enhances the binding of HDL to SR-BI. BLT-3 is applicable to research related to atherosclerosis and coronary heart disease.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 109940-24-1
- Formule: C19H13NO
- Masse moléculaire:271.32
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
BLT-3 inhibits SR-BI-mediated DiI uptake from DiI-HDL in ldlA[mSR-BI] cells, with an IC50 of 0.51 μM[1].
BLT-3 inhibits SR-BI-mediated [3H]CE uptake from [3H]CE-HDL in ldlA[mSR-BI] cells, with an IC50 of 2.3 μM[1].
BLT-3 inhibits SR-BI-mediated [3H]CE uptake from [3H]CE-HDL in Y1-BS1 cells, with an IC50 of 1.7 μM[1].
BLT-3 inhibits SR-BI-mediated [3H]cholesterol efflux to HDL in ldlA[mSR-BI] cells, with an IC50 of 17.2 μM[1].
BLT-3 enhances the binding of 125I-HDL to SR-BI in ldlA[mSR-BI] cells by increasing binding affinity (decreasing Kd and Koff) without altering Bmax, with an IC50 of 46.5 μM for its binding-enhancing effect[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 109940-24-1
-
Masse moléculaire 271.32
-
Formule C19H13NO
-
SMILES
N=1OC(C=2C=CC=CC2)=C3C=CC=C3C1C=4C=CC=CC4
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)